Cargando…

OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy

PURPOSE: To test optical coherence tomography leakage in the identification and quantification of choroidal neovascularization–related fluid, its change after anti–vascular endothelial growth factor therapy in neovascular age-related macular degeneration eyes and its relation to functional outcome....

Descripción completa

Detalles Bibliográficos
Autores principales: Farinha, Cláudia, Santos, Torcato, Santos, Ana Rita, Lopes, Marta, Alves, Dalila, Silva, Rufino, Cunha-Vaz, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176349/
https://www.ncbi.nlm.nih.gov/pubmed/30689620
http://dx.doi.org/10.1097/IAE.0000000000002470
_version_ 1783525001635299328
author Farinha, Cláudia
Santos, Torcato
Santos, Ana Rita
Lopes, Marta
Alves, Dalila
Silva, Rufino
Cunha-Vaz, José
author_facet Farinha, Cláudia
Santos, Torcato
Santos, Ana Rita
Lopes, Marta
Alves, Dalila
Silva, Rufino
Cunha-Vaz, José
author_sort Farinha, Cláudia
collection PubMed
description PURPOSE: To test optical coherence tomography leakage in the identification and quantification of choroidal neovascularization–related fluid, its change after anti–vascular endothelial growth factor therapy in neovascular age-related macular degeneration eyes and its relation to functional outcome. METHODS: Prospective analysis of a cohort of neovascular age-related macular degeneration cases treated with 2.0-mg intravitreal aflibercept. Eyes included were analyzed before, 1-week, and 1-month after one injection. Best-corrected visual acuity was assessed using Early Treatment Diabetic Retinopathy Study method. Optical coherence tomography leakage maps depicting low optical reflectivity (LOR) sites were acquired with OCT Cirrus AngioPlex (Zeiss, Dublin, CA). The LOR area ratio was correlated to retinal thickness and best-corrected visual acuity. Optical coherence tomography angiography was simultaneously performed. RESULTS: Twenty-two eyes of 18 patients with neovascular age-related macular degeneration were included. The LOR ratio of the full retina scan and retinal pigment epithelium–Bruch layer decreased from baseline to Month 1 (P < 0.05). Changes in retinal thickness and LOR ratio were positively correlated (P < 0.05). Best-corrected visual acuity change correlated with the outer segment layer LOR change (rho = −0.53, P = 0.014), and LOR was inferior in better responders (P = 0.021). Optical coherence tomography leakage identified eyes with recurrent fluid in the external layers. CONCLUSION: Optical coherence tomography leakage identified and quantified the fluid related to choroidal neovascularization activity. Low optical reflectivity change in the outer segment layer correlates with functional outcome and increasing LOR in the external layers may be a marker of early recurrence. Combining optical coherence tomography angiography and optical coherence tomography leakage allows both for choroidal neovascularization morphology and activity analysis.
format Online
Article
Text
id pubmed-7176349
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Retina
record_format MEDLINE/PubMed
spelling pubmed-71763492020-05-04 OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy Farinha, Cláudia Santos, Torcato Santos, Ana Rita Lopes, Marta Alves, Dalila Silva, Rufino Cunha-Vaz, José Retina Original Research PURPOSE: To test optical coherence tomography leakage in the identification and quantification of choroidal neovascularization–related fluid, its change after anti–vascular endothelial growth factor therapy in neovascular age-related macular degeneration eyes and its relation to functional outcome. METHODS: Prospective analysis of a cohort of neovascular age-related macular degeneration cases treated with 2.0-mg intravitreal aflibercept. Eyes included were analyzed before, 1-week, and 1-month after one injection. Best-corrected visual acuity was assessed using Early Treatment Diabetic Retinopathy Study method. Optical coherence tomography leakage maps depicting low optical reflectivity (LOR) sites were acquired with OCT Cirrus AngioPlex (Zeiss, Dublin, CA). The LOR area ratio was correlated to retinal thickness and best-corrected visual acuity. Optical coherence tomography angiography was simultaneously performed. RESULTS: Twenty-two eyes of 18 patients with neovascular age-related macular degeneration were included. The LOR ratio of the full retina scan and retinal pigment epithelium–Bruch layer decreased from baseline to Month 1 (P < 0.05). Changes in retinal thickness and LOR ratio were positively correlated (P < 0.05). Best-corrected visual acuity change correlated with the outer segment layer LOR change (rho = −0.53, P = 0.014), and LOR was inferior in better responders (P = 0.021). Optical coherence tomography leakage identified eyes with recurrent fluid in the external layers. CONCLUSION: Optical coherence tomography leakage identified and quantified the fluid related to choroidal neovascularization activity. Low optical reflectivity change in the outer segment layer correlates with functional outcome and increasing LOR in the external layers may be a marker of early recurrence. Combining optical coherence tomography angiography and optical coherence tomography leakage allows both for choroidal neovascularization morphology and activity analysis. Retina 2020-05 2019-01-24 /pmc/articles/PMC7176349/ /pubmed/30689620 http://dx.doi.org/10.1097/IAE.0000000000002470 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Research
Farinha, Cláudia
Santos, Torcato
Santos, Ana Rita
Lopes, Marta
Alves, Dalila
Silva, Rufino
Cunha-Vaz, José
OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title_full OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title_fullStr OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title_full_unstemmed OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title_short OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
title_sort optical coherence tomography leakage in neovascular age-related macular degeneration: identification of choroidal neovascularization activity by location and quantification of abnormal fluid under anti–vascular endothelial growth factor therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176349/
https://www.ncbi.nlm.nih.gov/pubmed/30689620
http://dx.doi.org/10.1097/IAE.0000000000002470
work_keys_str_mv AT farinhaclaudia opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT santostorcato opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT santosanarita opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT lopesmarta opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT alvesdalila opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT silvarufino opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy
AT cunhavazjose opticalcoherencetomographyleakageinneovascularagerelatedmaculardegenerationidentificationofchoroidalneovascularizationactivitybylocationandquantificationofabnormalfluidunderantivascularendothelialgrowthfactortherapy